Efficacy of Radiologic Screening for Distant Metastases and Second Primaries in Newly Diagnosed Patients With Head and Neck Cancer

2007 ◽  
Vol 117 (2) ◽  
pp. 242-247 ◽  
Author(s):  
Martin C. J??ckel ◽  
Andrea Reischl ◽  
Peter Huppert
Keyword(s):  
Head And Neck Cancer ◽  
Head And Neck ◽  
Neck Cancer ◽  
Distant Metastases ◽  
Newly Diagnosed ◽  
Second Primaries

scholarly journals The Impact of COVID-19 on Head and Neck Cancer Treatment: Before and During the Pandemic

OTO Open ◽  
2021 ◽  
Vol 5 (4) ◽  
pp. 2473974X2110680
Author(s):  
Roberto N. Solis ◽  
Mehrnaz Mehrzad ◽  
Samya Faiq ◽  
Roberto P. Frusciante ◽  
Harveen K. Sekhon ◽  
...  
Keyword(s):  
Head And Neck Cancer ◽  
Head And Neck ◽  
Neck Cancer ◽  
Care Center ◽  
Tertiary Care ◽  
Distant Metastases ◽  
Newly Diagnosed ◽  
Duration Of Symptoms ◽  
Time To Diagnosis ◽  
The Impact

Objectives To describe the impact that the coronavirus disease 2019 (COVID-19) pandemic had on the presentation of patients with head and neck cancer in a single tertiary care center. Study Design Retrospective cohort study. Setting Academic institution. Methods We performed a retrospective review of patients with newly diagnosed head and neck squamous cell carcinoma (HNSCC) who presented as new patients between September 10, 2019, and September 11, 2020. Patients presenting during the 6 months leading up to the announcement of the pandemic (pre–COVID-19 period) on March 11, 2020, were compared to those presenting during the first 6 months of the pandemic (COVID-19 period). Demographics, time to diagnosis and treatment, and tumor characteristics were analyzed. Results There were a total of 137 patients analyzed with newly diagnosed malignancies. There were 22% fewer patients evaluated during the COVID-19 timeframe. The groups were similar in demographics, duration of symptoms, time to diagnosis, time to surgery, extent of surgery, and adjuvant therapy. There was a larger proportion of tumors classified as T3/T4 (61.7%) in the COVID-19 period vs the pre–COVID-19 period (40.3%) ( P = .024), as well as a larger median tumor size during the COVID-19 period ( P = .0002). There were no differences between nodal disease burden ( P = .48) and distant metastases ( P = .42). Conclusion Despite similar characteristics, time to diagnosis, and surgery, our findings suggest that there was an increase in primary tumor burden in patients with HNSCC during the early COVID-19 pandemic.

Parameters influencing the risk of distant metastases in head and neck cancer

2002 ◽  
Vol 54 (2) ◽  
pp. 284-285
Author(s):  
M.O Al-Othman ◽  
W.M Mendenhall ◽  
C.G Morris ◽  
R.W Hinerman ◽  
R.J Amdur
Keyword(s):  
Head And Neck Cancer ◽  
Head And Neck ◽  
Neck Cancer ◽  
Distant Metastases

scholarly journals Does Quitting Smoking Make a Difference Among Newly Diagnosed Head and Neck Cancer Patients?

2016 ◽  
Vol 18 (12) ◽  
pp. 2216-2224 ◽  
Author(s):  
Seung Hee Choi ◽  
Jeffrey E. Terrell ◽  
Carol R. Bradford ◽  
Tamer Ghanem ◽  
Matthew E. Spector ◽  
...  
Keyword(s):  
Head And Neck Cancer ◽  
Head And Neck ◽  
Cancer Patients ◽  
Neck Cancer ◽  
Newly Diagnosed ◽  
Quitting Smoking

Incidence and Sites of Distant Metastases from Head and Neck Cancer

ORL ◽  
2001 ◽  
Vol 63 (4) ◽  
pp. 202-207 ◽  
Author(s):  
Alfio Ferlito ◽  
Ashok R. Shaha ◽  
Carl E. Silver ◽  
Alessandra Rinaldo ◽  
Vanni Mondin
Keyword(s):  
Head And Neck Cancer ◽  
Head And Neck ◽  
Neck Cancer ◽  
Distant Metastases

scholarly journals Times to Diagnosis, Staging, and Treatment of Head and Neck Cancer Before and During COVID-19

OTO Open ◽  
2021 ◽  
Vol 5 (4) ◽  
pp. 2473974X2110594
Author(s):  
Peter Yao ◽  
Victoria Cooley ◽  
William Kuhel ◽  
Andrew Tassler ◽  
Victoria Banuchi ◽  
...  
Keyword(s):  
Head And Neck Cancer ◽  
Head And Neck ◽  
Neck Cancer ◽  
Medical Center ◽  
Academic Medical Center ◽  
Head And Neck Cancers ◽  
Newly Diagnosed ◽  
Time To Treatment ◽  
Time To Diagnosis ◽  
The Times

Objective The coronavirus disease 2019 (COVID-19) pandemic has reduced the demand for, and supply of, head and neck cancer services. This study compares the times to diagnosis, staging, and treatment of head and neck cancers before and during the COVID-19 pandemic. Study Design Retrospective cohort study. Setting Tertiary academic medical center in New York City (NYC). Methods The times to diagnosis, staging, and treatment of head and neck cancer for patients presenting to the clinics of 4 head and neck oncology surgeons with newly diagnosed head and neck cancers were compared between pre–COVID-19 and COVID-19 periods. Results Sixty-eight patients in the pre–COVID-19 period and 26 patients in the COVID-19 period presented with newly diagnosed head and neck cancer. Patients in the COVID-19 group had a significantly longer time to diagnosis than the pre–COVID-19 group after adjustment for age and cancer diagnosis ( P = .02; hazard ratio [HR], 0.54; 95% CI, 0.32-0.92). Patients in the pre–COVID-19 and COVID-19 groups had no statistically significant differences in time to staging ( P > .9; HR, 1.01; 95% CI, 0.58-1.74) or time to treatment ( P = .12; HR, 1.55; 95% CI, 0.89-2.72). Conclusion This study found that time to diagnosis for head and neck cancers was delayed during a COVID-19 period compared to a pre–COVID-19 period. However, there was no evidence of delays in time to staging and time to treatment during the COVID-19 period. Our results prompt further investigations into the factors contributing to diagnostic delays but provide reassurance that despite COVID-19, patients were receiving timely staging and treatment for head and neck cancers.

Detection of Distant Metastases in Head and Neck Cancer: Changing Landscape

2018 ◽  
Vol 35 (2) ◽  
pp. 161-172 ◽  
Author(s):  
Remco de Bree ◽  
Asaf Senft ◽  
Andrés Coca-Pelaz ◽  
Luiz Kowalski ◽  
Fernando Lopez ◽  
...  
Keyword(s):  
Head And Neck Cancer ◽  
Head And Neck ◽  
Neck Cancer ◽  
Distant Metastases

Home and Inpatient Hospice Care of Terminal Head and Neck Cancer Patients

1997 ◽  
Vol 13 (1) ◽  
pp. 9-14 ◽  
Author(s):  
Yoav P. Talmi ◽  
Michaela Bercovici ◽  
Alexander Waller ◽  
Zeev Horowitz ◽  
Abraham Adunski
Keyword(s):  
Head And Neck Cancer ◽  
Head And Neck ◽  
Neck Cancer ◽  
Hospice Care ◽  
Oral Candidiasis ◽  
Distant Metastases ◽  
Treatment Protocols ◽  
Clinical Series ◽  
Lower Pain ◽  
Oral Cavity Tumor

The objective is to evaluate and compare data on a cohort of terminal head and neck cancer (HNC) patients from both home and hospital-based hospice programs and to define the particular problems and needs of those patients. The setting was a tertiary academic referral centre in Tel Hashomer, Israel. We carried out a retrospective survey of patient charts based on hospice databases and death certificates of the hospital tumor registry. Charts of 102 HNC patients admitted to the hospice between 1988 and 1994 and 24 charts of HNC patients cared for by the home hospice program between 1990 and 1994 were studied. Pain, airway problems, and dysphagia were the common problems reported. A comparison of the two programs showed home hospice patients to be younger and with lower pain levels, less weight loss, and less oral candidiasis. There were fewer oral cavity tumor patients in the home hospice group. The incidence of distant metastases was in the 50% range in both groups. Judging by chart entries relating to pain, airway care, and food intake, treatment protocols were effective in both programs in the alleviation of pain and other symptoms. Both programs appeared to provide adequate care for terminal HNC patients. The main differences in care between the two groups stemmed from the decisions of referring physicians and not from a predetermined level of care. The incidence of distant metastases was higher than that reported in earlier clinical series.

Sign in / Sign up

Export Citation Format

Share Document